Update on Moberg and Part 2 of the Write-Up Series

Obviously, a lot has changed with Moberg recently. I was going to release my next writeup/models on Sunday (yesterday), but with the news on Friday, most of what I had written is no longer relevant. Also, to publish it now would leave me open to accusations of having written it with the benefit of hindsight, and we don’t need that.

I cut my losses on Friday in their entirety and thus have no stake in Moberg at this time, nor will I at least as long as the current management team is in place.

In the time since their press release, it has become an absolute mess and I have zero insight into how anyone involved (management, shareholders, regulatory bodies) will behave going forward. This bungling of the clincal research process and subsequent investor relations has been disappointing to say the least.

It may still work out. The press release actually tells us very little about the viability of the product/markets, so I don’t blame those who are staying or doubling down, but there is simply too much uncertainty now for me, and to maintain a position here would be tantamount to gambling (for me).

While things didn’t play out the way I had hoped, I’m proud of the work I did on the name and enjoyed the time spent with many of you in the digging. I believe it was a well-reasoned bet that went bad due to a combination of potentially intuitable factors. I’ve taken many lessons from my first major defeat, and I will be applying them to future efforts with other names going forward. I hope you’ll stick with me, but I can understand not doing so.

Over and out.